Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Higher-risk Myelodysplastic Syndrome × luspatercept × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Anemia 4 Primary Myelofibrosis 3 beta-Thalassemia 2 Leukemia, Myeloid, Acute 2 Thrombocytosis 1 Higher-risk Myelodysplastic Syndrome 1 Granulosa cell tumor of the ovary 1

Interventions

luspatercept 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06927232 2025-04-15

AZA+Lus VS AZA Monotherapy in HR-MDS

Peking Union Medical College Hospital

Phase 3 Not yet recruiting

Higher-risk Myelodysplastic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡